DE60226253D1 - Humanisierter antikörper gegen fibroblastenwachstumsfaktor 8 und fragment des antikörpers - Google Patents

Humanisierter antikörper gegen fibroblastenwachstumsfaktor 8 und fragment des antikörpers

Info

Publication number
DE60226253D1
DE60226253D1 DE60226253T DE60226253T DE60226253D1 DE 60226253 D1 DE60226253 D1 DE 60226253D1 DE 60226253 T DE60226253 T DE 60226253T DE 60226253 T DE60226253 T DE 60226253T DE 60226253 D1 DE60226253 D1 DE 60226253D1
Authority
DE
Germany
Prior art keywords
antibody
antibody fragment
growth factor
fibroblast growth
fragment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60226253T
Other languages
English (en)
Other versions
DE60226253T2 (de
Inventor
Kenya Shitara
Kazuyasu Nakamura
Maiko Hirota
Naoki Shimada
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kyowa Kirin Co Ltd
Original Assignee
Kyowa Hakko Kogyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Kogyo Co Ltd filed Critical Kyowa Hakko Kogyo Co Ltd
Publication of DE60226253D1 publication Critical patent/DE60226253D1/de
Application granted granted Critical
Publication of DE60226253T2 publication Critical patent/DE60226253T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565—Complementarity determining region [CDR]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE60226253T 2001-06-28 2002-06-28 Humanisierter antikörper gegen fibroblastenwachstumsfaktor 8 und fragment des antikörpers Expired - Lifetime DE60226253T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2001196176 2001-06-28
JP2001196176 2001-06-28
PCT/JP2002/006591 WO2003002608A1 (en) 2001-06-28 2002-06-28 Humanized antibody against fibroblast growth factor-8 and fragment of the antibody

Publications (2)

Publication Number Publication Date
DE60226253D1 true DE60226253D1 (de) 2008-06-05
DE60226253T2 DE60226253T2 (de) 2009-05-14

Family

ID=19034030

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60226253T Expired - Lifetime DE60226253T2 (de) 2001-06-28 2002-06-28 Humanisierter antikörper gegen fibroblastenwachstumsfaktor 8 und fragment des antikörpers

Country Status (9)

Country Link
US (1) US7939077B2 (de)
EP (1) EP1422243B1 (de)
JP (1) JP4152315B2 (de)
AT (1) ATE393170T1 (de)
AU (1) AU2002346127B2 (de)
CA (1) CA2451854A1 (de)
DE (1) DE60226253T2 (de)
ES (1) ES2303859T3 (de)
WO (1) WO2003002608A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7241568B2 (en) 1996-04-03 2007-07-10 Kyowa Hakko Kogyo Co., Ltd. Anti-fibroblast growth factor-8 monoclonal antibody
US7521053B2 (en) 2001-10-11 2009-04-21 Amgen Inc. Angiopoietin-2 specific binding agents
US7658924B2 (en) 2001-10-11 2010-02-09 Amgen Inc. Angiopoietin-2 specific binding agents
DE60232101D1 (de) * 2001-12-28 2009-06-04 Kyowa Hakko Kogyo Kk
US20070009957A1 (en) * 2003-03-04 2007-01-11 Alexion Pharmaceuticals, Inc. Vectors used to create hybrid constant regions
WO2006121159A1 (ja) * 2005-05-12 2006-11-16 Kyowa Hakko Kogyo Co., Ltd. Cd10に特異的に反応するヒト型cdr移植抗体およびその抗体断片
KR20090029227A (ko) 2006-06-06 2009-03-20 교와 핫꼬 기린 가부시키가이샤 헤파린 결합 상피세포 증식 인자 유사 증식 인자에 결합하는 모노클로날 항체
CA2707689A1 (en) 2007-12-05 2009-06-11 Kyowa Hakko Kirin Co., Ltd. Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factor
JO2913B1 (en) 2008-02-20 2015-09-15 امجين إنك, Antibodies directed towards angiopoietin-1 and angiopoietin-2 proteins and their uses
DK2156949T3 (en) 2008-08-19 2015-02-16 Cryovac Inc For vacuum skin packaging applications suitable film and thus produced vacuum skin pack is easy to open

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US5225539A (en) 1986-03-27 1993-07-06 Medical Research Council Recombinant altered antibodies and methods of making altered antibodies
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
DK0573510T3 (da) * 1991-01-17 1998-04-27 Univ Washington Antivækstfaktor antistoffer i behandlingen af vaskulær stenose
JP3708210B2 (ja) 1996-04-03 2005-10-19 協和醗酵工業株式会社 抗線維芽細胞増殖因子−８モノクローナル抗体
JP4550947B2 (ja) * 1997-03-19 2010-09-22 協和発酵キリン株式会社 ガングリオシドｇｍ２に対するヒト型相補性決定領域（ｃｄｒ）移植抗体
JP2001046066A (ja) * 1999-08-03 2001-02-20 Kyowa Hakko Kogyo Co Ltd 新規な相補性決定領域を有するヒトｖｅｇｆ受容体ｋｄｒに対する抗体

Also Published As

Publication number Publication date
EP1422243A1 (de) 2004-05-26
JPWO2003002608A1 (ja) 2004-10-14
WO2003002608A1 (en) 2003-01-09
AU2002346127B2 (en) 2008-05-29
CA2451854A1 (en) 2003-01-09
ATE393170T1 (de) 2008-05-15
US20040253234A1 (en) 2004-12-16
EP1422243A4 (de) 2005-05-04
DE60226253T2 (de) 2009-05-14
ES2303859T3 (es) 2008-09-01
EP1422243B1 (de) 2008-04-23
JP4152315B2 (ja) 2008-09-17
US7939077B2 (en) 2011-05-10

Similar Documents

Publication Publication Date Title
WO2004048525A3 (en) Therapy of non-malignant diseases or disorders with anti-erbb2 antibodies
ATE470676T1 (de) Anti-vegf-2 antikörper
MXPA02011656A (es) Moleculas de acido nucleico nrg-2, polipeptidos, y metodos de diagnostico y terapeuticos.
MXPA02002384A (es) Polipeptidos similares al factor de crecimiento de fibroblastos.
ZA200508389B (en) Humanized antibodies to interferon alpha receptor-1(IFNAR-1)
ATE482234T1 (de) Antikörper gegen kdr, deren herstellung und verwendungen
HK1087018A1 (en) Peptide-based passive immunization therapy for treatment of atherosclerosis
WO2002083171A3 (en) Cancer treatment by using fap-alpha specific antibodies
DE60226253D1 (de) Humanisierter antikörper gegen fibroblastenwachstumsfaktor 8 und fragment des antikörpers
ATE439381T1 (de) Reinigung von polyreaktiven autoantikörpern und deren verwendungen
BR0308606A (pt) Derivados de hemiasterlina e usos destes
WO2002081745A3 (en) Genes involved in osteogenesis, and methods of use
RS8504A (en) Novel cyclohexil sulphones
WO2004076614A3 (de) Humane nukleinsäuresequenzen aus prostatakarzinomen
WO2003048317A3 (en) Antibodies to magmas and uses thereof
BRPI0415355A (pt) triarilimidazóis
ITGE20020050A1 (it) Procedimento per il trattamento di filati mediante agugliatura.
AU2002326285A1 (en) Method for treating psoriasis by using an il-17d antagonist
WO2004030607A3 (en) Peptide-based passive immunization therapy for treatment of atherosclerosis
WO2003037257A3 (en) Methods and compositions for the diagnosis and treatment of cellular proliferation disorders using 20750
ATE328082T1 (de) Verkürztes bard1 protein und dessen diagnostische und therapeutische anwendungen
EP1566386A4 (de) Gen in zusammenhang mit haarausfall, das davon kodierte polypeptid und anwendungen dafür
ATE397753T1 (de) Screening-verfahren für eine prophylaktische und therapeutische substanz für eine nierenerkrankung
WO2004037179A3 (en) Substituted peptides useful in the treatment of alzheimer’s disease
WO2001094530A3 (fr) Nouveau polypeptide, proteine 57 de la sous-famille des proteines a doigt de zinc scan, et polynucleotide codant ce polypeptide

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: KYOWA HAKKO KIRIN CO., LTD., TOKYO, JP